Table 1 Patient Comparison of LVNC and NIDCM
|  | Individuals with ≥ 3 segments with non-compacted:compacted ratio ≥ 2.3n = 18 (%) | Individuals with < 3 segments with non-compacted:compacted ratio < 2.3 n = 53 (%) | p-value |
|---|---|---|---|
Baseline Characteristics: | Â | Â | Â |
Males | 7 (38.9) | 32 (60.4) | Â |
Mean Age in Years | 50.9 +/- 17.9 | 50.4 +/- 15.3 | 0.907 |
History of CVA | 1 (5.6) | 1 (1.9) | 0.416 |
History of Diabetes Mellitus | 4 (22.2) | 16 (30.2) | 0.516 |
History of Hypertension | 9 (50) | 27 (50.9) | 0.945 |
History of ESRD | 0 (0) | 1 (1.9) | 0.557 |
History of Cancer with Exposure to Chemotherapy/Radiation | 3 (16.7) | 7 (13.2) | 0.715 |
Outcomes: | Â | Â | Â |
Average Number of Heart Failure Admissions per Patient | 0.83 +/- 1.0 | 0.73 +/- 1.2 | 0.747 |
Thromboembolic Events | 2 (11) | 3 (5.7) | 0.435 |
SVT | 6 (33.3) | 10 (18.9) | 0.204 |
NSVT or VT | 2 (11.1) | 11 (20.8) | 0.473 |
Underwent ICD Placement | 6 (33.3) | 10 (18.9) | 0.393 |
Underwent LVAD placement | 1 (5.6) | 0 (0) | 0.084 |
Underwent Heart Transplantation | 0 (0) | 0 (0) | -- |
Mortality | 0 (0) | 1 (1.9) | 0.557 |
CMR features: | Â | Â | Â |
LV EF (%) | 36.0 +/- 17.9 | 36.1 +/- 12.7 | 0.992 |
LV End Diastolic Volume Index (mL/m2) | 139.0 +/- 49.0 | 122.0 +/- 41.4 | 0.157 |
LV End Systolic Volume Index (mL/m2) | 93.8 +/- 53.6 | 81.9 +/- 41.6 | 0.333 |
LV Mass Index (g/m2) | 58.9 +/- 19.5 | 65.0 +/- 20.8 | 0.277 |
RV EF (%) | 45.4 +/- 12.4 | 46.1 +/- 10.3 | 0.816 |
RV End Diastolic Volume Index (mL/m2) | 88.3 +/- 24.3 | 84.8 +/- 27.7 | 0.634 |
RV End Systolic Volume Index (mL/m2) | 47.6 +/- 22.6 | 47.1 +/- 22.5 | 0.927 |
LA Volume Index (mL/m2) | 64.6 +/- 18.7 | 54.8 +/- 23.9 | 0.122 |